Press releases

FRANKLIN LAKES, N.J. (Aug. 1, 2024) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Patrick Jeukenne has been named worldwide...

Strong Margin Execution Drives Performance in Quarter Revenue of $5.0 billion as reported, adjusted revenue of $5.1 billion, driven by strong organic revenue growth GAAP and adjusted diluted EPS...

Collaboration on Flow Cytometry-Based Companion Diagnostics to Advance Personalized Health Care FRANKLIN LAKES, N.J. and SECAUCUS, N.J., July 25, 2024 /PRNewswire/ -- BD (Becton, Dickinson and...

The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has declared a quarterly dividend of $0.95 per common...

Company Committed to Support Global Health and Customers BD Taking all Available Measures to Mitigate Supplier Issue FRANKLIN LAKES, N.J., July 10, 2024 /PRNewswire/ -- BD (Becton, Dickinson and...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has surpassed its Scope 1 and 2 science-based greenhouse gas (GHG) emissions...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will report financial results for its third quarter of fiscal year 2024 on...

BD Rhapsody™ ATAC-Seq Assay Helps Researchers Understand DNA Regulation and Enable Advancements in Precision Medicine FRANKLIN LAKES, N.J., June 26, 2024 /PRNewswire/ -- BD (Becton, Dickinson...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it plans to host webcasts to discuss quarterly financial results on the following...

FRANKLIN LAKES, N.J. (June 13, 2024) – BD (Becton, Dickinson and Company), a leading global medical technology company, today released its 2023 Product Security Annual Report to update customers...

FRANKLIN LAKES, N.J. (June 6, 2024) – BD (Becton, Dickinson and Company), a leading global medical technology company, was named to USA TODAY’s 2024 list of America’s Climate Leaders,...

Combination unlocks new future value-creation opportunities and is expected to be immediately accretive to BD revenue growth, adjusted gross margin, adjusted operating margin and adjusted EPS...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced U.S. Food and Drug Administration (FDA) approval for the use of self-collected vaginal...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Rima Alameddine has been named worldwide president of the BD Peripheral Intervention business unit, effective today.

New program to equip future pharmacists with industry exposure and hands-on experience with medication dispensing technology FRANKLIN LAKES, N.J. (May 6, 2024) – BD (Becton, Dickinson and...

Margin Execution Drives Better Performance in Quarter and Higher Guidance for Fiscal 2024 Q2 revenue of $5.0 billion increased 4.6% as reported, 4.7% currency-neutral and 5.7% organic Q2 GAAP and...

The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has declared a quarterly dividend of $0.95 per common...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Bank of America Securities Health Care Conference 2024 on...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will receive the Business Group on Health "Best Employers: Excellence in Health...

New BD FACSDiscover™ S8 Cell Sorters to Enable More Researchers to Push the Boundaries of Discovery FRANKLIN LAKES, N.J., April 5, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE:...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will report financial results for its second quarter of fiscal year 2024 on...

Most Americans Unaware of Challenges from Common Hospital Procedures FRANKLIN LAKES, N.J., March 27, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today was named to Fortune's 2024 list of America's Most Innovative Companies. "At BD, innovation is...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued the following statement regarding the March 19, 2024 U.S. Food and Drug Administration...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and a consortium of health care institutions in Denmark have innovated a method to recycle used blood...